ClinicalTrials.gg
Enrolling by invitationNCT07759063Updated Aug 11, 2026

Clinical Validation of Self-Pacing Algorithms on Step Length Symmetry in Hemiplegic Populations

An interventional study of Walking on self-pacing treadmill and Walking on fixed-pacing treadmill in Stroke and Traumatic Brain Injury, sponsored by Quality Living, Inc.. Enrolling by invitation at 1 site in United States. Open to participants aged 19 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-08-11.

Sponsored by Quality Living, Inc. · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
19 Years to 75 Years
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate the efficacy of self-pacing algorithms in promoting step-length equalization in people with weakness on one side of the body. The main question it aims to answer is:

  • How does walking on a treadmill that uses self-pacing algorithms to adjust speed affect stride length in comparison to walking on a treadmill without self-pacing capability? Researchers will compare study participants to themselves when walking on a self-pacing treadmill compared to walking on a fixed-pacing treadmill to see if a difference exists in the equalization of left- and right-sided stride length.

Participants will walk for two minutes at a self-selected pace to warm up and establish a baseline walking speed. They will then walk for 1 - 3 minutes either on a self-pacing treadmill or a fixed-pacing treadmill. A 3-minute seated rest break will follow. Then participants will walk for another 1 - 3 minutes using the treadmill not used in the first walking trial.

Read the detailed description

The chosen treadmill has self-pacing algorithms installed that adjust speed as a person walks. This allows a person to increase or decrease speed as desired throughout a walking session. Researchers have not yet determined the effect of using a self-pacing treadmill on left-right gait equalization among people with acquired hemiparesis secondary to stroke or traumatic brain injury. The researchers will compare measurement data captured by the system software when participants walk on the treadmill with the self-pacing feature turned on versus off. Each walking trial will last 1 - 3 minutes and will occur in a random order during a single research session. The randomization is to ensure that fatigue is not a factor when interpreting results.

02

Conditions studied

  • Stroke
  • Traumatic Brain Injury

Keywords

  • gait
  • hemiparesis
  • physical therapy
  • walking
03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's planned enrollment of 30 is below the median of 49 across 6,024 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Quality Living, Inc. is the lead sponsor of 8 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Current client of Quality Living, Inc., in Omaha, NE
  • 19 to 75 years of age
  • Speak and understand English
  • Can ambulate overground for at least 10 minutes with or without use of aids
  • Medically cleared for treadmill exercise
  • Hemiparesis secondary to stroke or traumatic brain injury

Exclusion criteria

Exclusion Criteria:

  • Has not retained power of attorney for healthcare
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Self-pacing treadmill walking first, then fixed-pacing treadmill walking

    Behavioral: Walking on self-pacing treadmill · Behavioral: Walking on fixed-pacing treadmill

  • Experimental
    Fixed-pacing treadmill walking first, then self-pacing treadmill walking

    Behavioral: Walking on self-pacing treadmill · Behavioral: Walking on fixed-pacing treadmill

Interventions

  • BehavioralWalking on self-pacing treadmill

    Contrast with walking on fixed-pacing treadmill.

  • BehavioralWalking on fixed-pacing treadmill

    Contrast with walking on self-pacing treadmill.

06

What researchers measure

Primary outcomes

  1. Difference in step length symmetry with self-pacing versus fixed-pacing treadmill walking

    Non-hemiparetic side step length minus hemiparetic side step length when walking on self-pacing versus fixed pacing treadmill.

    Time frame: 1-3 minutes of walking on self-pacing treadmill and 1-3 minutes of walking on fixed-pacing treadmill during a single experimental session.

  2. Difference in step-length on hemiparetic and non-hemiparetic sides

    Length of forward movement of each foot during each walking step as measured in centimeters.

    Time frame: 1-3 minutes of walking on self-pacing treadmill and 1-3 minutes of walking on fixed-pacing treadmill.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data will be available in deidentified form from the principal investigator.

Supporting information: Study protocol, Clinical study report

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07759063
Lead sponsor
Quality Living, Inc.
Responsible party
Karen Hux, Ph.D. (Director of Research, Quality Living, Inc.) — Principal investigator
First posted
Aug 11, 2026
Start date
Aug 15, 2026 (estimated)
Primary completion
Aug 1, 2027 (estimated)
Completion
Aug 1, 2028 (estimated)
Last update
Aug 11, 2026

Study contacts

Karen Hux, Ph.D.
study director · Quality Living, Inc.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion